Adolescents and young adults who have undergone cancer treatment are at a substantially increased risk of developing new tumors years after their initial diagnosis. This finding, emerging from a recent study conducted in Alberta, underscores the critical need for enhanced follow-up care and screening programs for this demographic.

Alberta Study Highlights Long-Term Risks

The research, published in the Canadian Medical Association Journal, tracked nearly 25,000 young adults in Alberta diagnosed with cancer between 1983 and 2017. The study revealed that approximately 6% of these individuals developed a subsequent cancer, separate from a recurrence of their original disease.

A significant concern is that many of these secondary cancers appeared after patients had passed the five-year survival mark, a point at which they are often discharged from specialized cancer care systems. This transition can leave survivors without adequate guidance on ongoing surveillance needs.

Factors Contributing to Increased Risk

Several factors contribute to the elevated risk of new cancers in young survivors. Treatments like radiation therapy, certain chemotherapy agents, and hormone therapies are known to increase the likelihood of developing secondary malignancies. Lifestyle choices and genetic predispositions can also play a role.

However, the study authors noted that much existing research on subsequent cancer risk in young adults is based on childhood cancer survivors, who typically receive more consistent follow-up. This can lead to young adults being overlooked in research and experiencing gaps in their care.

Specific Cancers and Treatment Impacts

Survivors of Hodgkin lymphoma and breast cancer showed a particularly elevated risk, likely due to the common use of chest radiation in their treatment. The median age at diagnosis for these subsequent cancers in survivors is also lower than the average age of first diagnosis in the general Canadian population.

Gaps in Follow-Up Care and Screening

While robust screening programs exist for pediatric cancer survivors, consistent support for young adult survivors across Canada is not uniform. Screening policies vary by province, leading to disparities in patient care and follow-up.

Dr. Abha Gupta, medical director of the adolescent and young adult cancer program at the Princess Margaret Cancer Centre in Toronto, highlighted this disparity. She explained that while long-term follow-up for childhood cancer survivors is well-established, young adults often lack similar comprehensive support systems.

Tyler Cavanaugh, a survivor and patient advisor for the study, echoed this sentiment. He observed that childhood survivors typically receive ongoing monitoring, while young adults often experience a significant reduction in care after their initial treatment concludes. He stressed the importance of future screening and prevention strategies tailored to this group.

The study's findings strongly suggest a need for enhanced awareness, improved follow-up protocols, and the development of more accessible, tailored screening programs for adolescent and young adult cancer survivors across Canada.